Search
for
Sort by
Research 631–660 of 1000+
- Analysing Alopecia Areata with the Trichoscopic Eye: Markers of Disease Severity, Disease Activity, Novel Findings and Association with Trichotillomania
- 068 Pathogenic Th17 cells, CD8+CD69+CD49a- tissue-resident memory T cells and common γ chain receptor + natural killer cells express more IL-17, compared to IFN-γ, under the foxp3+ memory regulatory T cells-depleted microenvironment in patients with chronic alopecia areata
- Loose anagen hair syndrome: An unusual cause of alopecia in a child
- Steroid topical therapy and pulse dosing therapy for multifocal alopecia areata
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Advances in the management of alopecia areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Nail Involvement in Alopecia Areata: A Questionnaire-based Survey on Clinical Signs, Impact on Quality of Life and Review of the Literature
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- A Potential Predictive Role of the Scalp Microbiome Profiling in Patients with Alopecia Areata: Staphylococcus caprae, Corynebacterium, and Cutibacterium Species
- The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms
- Alopecia Areata of the Nails: Diagnosis and Management
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Alopecia Areata: Clinical Treatment
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Alopecia Areata: Current and Emerging Therapies
- Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates
- Synergistic therapeutic effect of systemic steroids and dithranol in a patient of alopecia totalis—A case report
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease Pathways
- Baricitinib in Dermatology: Expanding Therapeutic Horizons Beyond Alopecia Areata